AAV vectors are currently among the most commonly applied for in vivo gene therapy methods. The evaluation of vectors during clinical development requires the production of considerable amounts of highly pure and potent vectors. The scale of production is mainly determined by the number of virus particles required per batch.
https://qvirus.creative-biogen....e.com/services/gmp-a
Like
Comment
Share
